[go: up one dir, main page]

FR2410013A1 - Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd. - Google Patents

Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd.

Info

Publication number
FR2410013A1
FR2410013A1 FR7735250A FR7735250A FR2410013A1 FR 2410013 A1 FR2410013 A1 FR 2410013A1 FR 7735250 A FR7735250 A FR 7735250A FR 7735250 A FR7735250 A FR 7735250A FR 2410013 A1 FR2410013 A1 FR 2410013A1
Authority
FR
France
Prior art keywords
acid
deriv
cpd
soln
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7735250A
Other languages
French (fr)
Other versions
FR2410013B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitika Ltd
Original Assignee
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unitika Ltd filed Critical Unitika Ltd
Priority to FR7735250A priority Critical patent/FR2410013A1/en
Publication of FR2410013A1 publication Critical patent/FR2410013A1/en
Application granted granted Critical
Publication of FR2410013B1 publication Critical patent/FR2410013B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005Use of materials characterised by their function or physical properties
    • A61L33/0011Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Prodn. of antithrombogenic polymer materials comprises treating a polymer material (I) with a soln. of a synthetic fibrinolytic cpd. (II) so that (II) is attached to (I) by chemical bonding or adsorption. (II) can be a 1,2-diphenylpyrazolidine deriv. (e.g. phenylbutazone), an anthranilic acid deriv. (e.g. mefenamic acid), a salicylic acid), a salicyclic acid deriv. (e. g. a chlorobenzyl-salicyclic acid), a cinnamic acid deriv. (e.g. an alpha-alkyl-halocinnamic acid), a Beta-aryl-substd. aliphatic acid (e.g. Beta-phenyl-n-butyric acid) or a heterocyclic carboxylic acid deriv. (e.g. niflumic acid). The process can be used to treat polymer articles coming into direct contact with blood, e.g. prosthetic devices, catheters, artificial organs and suture materials. The coating of (II) is easy to apply (even to complicated shapes) and provides long lasting inhibition of thrombus formation.
FR7735250A 1977-11-23 1977-11-23 Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd. Granted FR2410013A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7735250A FR2410013A1 (en) 1977-11-23 1977-11-23 Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7735250A FR2410013A1 (en) 1977-11-23 1977-11-23 Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd.

Publications (2)

Publication Number Publication Date
FR2410013A1 true FR2410013A1 (en) 1979-06-22
FR2410013B1 FR2410013B1 (en) 1984-09-14

Family

ID=9197958

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7735250A Granted FR2410013A1 (en) 1977-11-23 1977-11-23 Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd.

Country Status (1)

Country Link
FR (1) FR2410013A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2071904A5 (en) * 1969-12-08 1971-09-17 Baxter Laboratories Inc
US3625745A (en) * 1970-03-18 1971-12-07 Gen Electric Antithrombogenic article and process
FR2142277A5 (en) * 1971-06-18 1973-01-26 Gen Electric Antithrombogenic surfaces
FR2187849A1 (en) * 1972-06-06 1974-01-18 Atomic Energy Commission
FR2399836A1 (en) * 1977-07-27 1979-03-09 Snam Progetti PROCESS FOR PREPARING BIOCOMPATIBLE PRODUCTS AND ARTICLES THUS OBTAINED

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2071904A5 (en) * 1969-12-08 1971-09-17 Baxter Laboratories Inc
US3625745A (en) * 1970-03-18 1971-12-07 Gen Electric Antithrombogenic article and process
FR2142277A5 (en) * 1971-06-18 1973-01-26 Gen Electric Antithrombogenic surfaces
FR2187849A1 (en) * 1972-06-06 1974-01-18 Atomic Energy Commission
FR2399836A1 (en) * 1977-07-27 1979-03-09 Snam Progetti PROCESS FOR PREPARING BIOCOMPATIBLE PRODUCTS AND ARTICLES THUS OBTAINED

Also Published As

Publication number Publication date
FR2410013B1 (en) 1984-09-14

Similar Documents

Publication Publication Date Title
AU8123694A (en) Intravascular medical device
FI893660A0 (en) BELAGT BIOFOERENLIGT MATERIAL.
ES2097972T3 (en) DEVICE TO PREVENT ARTERIAL RESTENOSIS.
ATE170129T1 (en) METHOD FOR COATING POLYMER SURFACES AND COATED PRODUCTS PRODUCED THEREFORE
ES8106909A1 (en) Process for preparing macromolecular biologically active collagen
ATE63451T1 (en) PROCEDURE FOR PRODUCING A SURFACE FOR TISSUE GROWTH IN SURGICAL IMPLANTS.
YU47291B (en) CONTROLLER FOR CONTROLLED DROPPING OF NICOTINE AND PROCEDURE FOR ITS MANUFACTURING
NO159698C (en) PROCEDURE FOR PASTEURIZATION OF HUMAN FIBRINOGE
DE69121561D1 (en) USE OF 3-GUANIDINOPROPIONIC ACID FOR PRODUCING A MEDICINE FOR TREATING AND PREVENTING FAT ADDICTION
DE3869230D1 (en) METHOD FOR PRODUCING A SOLUTION OF HIGH SPECIFIC VOLUME ACTIVITY FROM A PROTEIN WITH TISSUE PLASMINOGEN ACTIVATOR (T-PA) ACTIVITY, SOLUTION, CONTAINING PROTEIN WITH T-PA ACTIVITY AND USE OF THE SOLUTION AND IN THE HUMAN VITALIZE.
DE68904462D1 (en) 4-CHINOLINE CARBONIC ACID DERIVATIVES, USEABLE FOR TREATING SKIN AND MUCO EPITHELIAL TISSUE DISEASES.
FR2575479B1 (en) AMPHOTERIC COPOLYMERS, THEIR MANUFACTURING PROCESS AND THEIR APPLICATION TO WATER RETENTION
FR2541119B1 (en) PROGRAMMING ELECTRONIC DEVICE FOR STIMULATING AND CONTROLLING MUSCLE CONTRACTION, ESPECIALLY SMOOTH MUSCLES OF VASCULAR TISSUE
FR2410013A1 (en) Polymer articles prodn. with reduced thrombogenic tendency - by treating with soln. of synthetic fibrinolytic cpd.
ATE89728T1 (en) USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR THE LOCAL TREATMENT OF TROPHIC DISORDERS.
DE3374071D1 (en) Method of manufacturing a prosthetic device having a coating of bio-compatible carbonaceous material and a prosthetic device having such a coating
DE3672987D1 (en) DEVICE FOR CARRYING OUT THE ACUPUNCTURE.
DE3766619D1 (en) USE OF DICARBONIC ACIDS WITH 7-13 CARBON ATOMS OR PHYSIOLOGICALLY COMPATIBLE SALTS THEREOF FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR TOPICAL TREATMENT OF ROSAZEA.
DE2964492D1 (en) Use of dispersions of polymers of conjugated dienes, allylsulfonic acids and acrylic acid derivatives for treating leather
DE69026511D1 (en) USE OF GIBBERELLINES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING PROSTATITIS
IT7967238A0 (en) ACRYLONITRILE COPOLYMERS SUBSTANTIALLY FREE FROM RESIDUAL MONOMERS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE FOR THE PRODUCTION OF ORTHOPEDIC SHAPED BODIES
DE69937892D1 (en) IMPLANT MATERIAL
SE7903262L (en) PROCEDURE FOR MANUFACTURE OF BIO-COMPATIBLE MATERIALS
ES2176349T3 (en) SILILATION PROCESS.
DE3882422D1 (en) COPOLYMERISATE OF UNSATURATED CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE.

Legal Events

Date Code Title Description
ST Notification of lapse